The primacy of humoral antibody (complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity) in concordant xenograft rejection.
Araneda
D
D
East Carolina University School of Medicine/University Medical Center, Greenville, NC 27858.
Thomas
F T
FT
Ljung
T
T
Cekada
E
E
Pittman
K
K
D000818:Animals; D000917:Antibody Formation; D000920:Antibody-Dependent Cell Cytotoxicity / Q000276:immunology*; D003165:Complement System Proteins / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D006084:Graft Rejection / Q000276:immunology*; D006085:Graft Survival / Q000187:drug effects; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology; D051381:Rats; D011923:Rats, Nude; D013156:Splenectomy; D013601:T-Lymphocytes / Q000276:immunology
D007166:Immunosuppressive Agents; D003165:Complement System Proteins